poisar

Stocks · News reference

Annexin Pharmaceuticals Completes Patient Recruitment for Clinical Study

Fiscal.ai

Annexin Pharmaceuticals has finalized patient recruitment for its ongoing clinical study, setting the stage for topline data expected by the end of the first quarter of 2027.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading